Research - Abstracts from the upcoming American Society of Clinical Oncology (ASCO) annual meeting are out, published on Wednesday evening. The totality of data present in the abstracts isn’t … Continue Reading
Read NowResearch - Sarepta (SRPT) will file a NDA and get 5 new trials off the ground in the next 7 months.
Read NowResearch - Orexigen's (OREX) PDUFA data is next month for NB32. The stock is off 30% from its highs, and given a high chance of an approval, the long trade is attractive.
Read NowResearch - The American Society of Clinical Oncology (ASCO) annual meeting is right around the corner, and healthcare investors will have a close eye on ASCO for … Continue Reading
Read NowResearch - Albany Molecular (AMRI) management's ability to execute on an aggressive growth plan is central to the long thesis.
Read NowResearch - Synergy's phase 2 IBS-C results were, in our view, better than expected. But the market took a dim view of the stock on Wednesday for a number of reasons, outlined here.
Read NowResearch - Ironwood (IRWD) had a good quarter, and the next few quarters should look even better as an advertising campaign kicks off.
Read Now
